|Mr. David J. Schlanger||Executive Chairman||510.41k||42.22M||1959|
|Mr. Peter Anevski||CEO & Director||1.01M||11.97M||1967|
|Mr. Michael Sturmer||President||761.5k||N/A||1977|
|Mr. Mark S. Livingston||Chief Financial Officer||693.87k||N/A||1966|
|Ms. Allison Swartz||Executive VP, General Counsel & Secretary||173.35k||N/A||1990|
|Mr. James Hart||Vice President of Investor Relations||N/A||N/A||N/A|
|Ms. Risa Fisher||Executive VP & Chief Marketing Officer||N/A||N/A||N/A|
|Ms. Cassandra Pratt||Senior VP of People||N/A||N/A||N/A|
|Ms. Julie Stadlbauer||Executive Vice President of Strategic Sales & Partnerships||N/A||N/A||N/A|
|Ms. Janet Choi M.D.||Member of the Medical Advisory Board & Chief Medical Officer||N/A||N/A||N/A|
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Progyny, Inc.’s ISS governance QualityScore as of 28 November 2023 is 9. The pillar scores are Audit: 1; Board: 8; Shareholder rights: 7; Compensation: 10.